Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Clinical cancer research, 2017-06, Vol.23 (12), p.3012-3024 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jun 15, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-16-2554 ;PMID: 28039262
Full text available